Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Pharmaceutical CDMO Services Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Pharmaceutical CDMO Services Market Status and Forecast (2016-2027)
      • 1.3.2 Global Pharmaceutical CDMO Services Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Pharmaceutical CDMO Services Supply by Company

    • 2.1 Global Pharmaceutical CDMO Services Sales Value by Company
    • 2.2 Pharmaceutical CDMO Services Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Pharmaceutical CDMO Services Market Status by Category

    • 3.1 Pharmaceutical CDMO Services Category Introduction
      • 3.1.1 Drug Substance Development and Manufacturing
      • 3.1.2 Specialized Services
      • 3.1.3 Lab-based Services
    • 3.2 Global Pharmaceutical CDMO Services Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Pharmaceutical CDMO Services Market Status by End User/Segment

    • 4.1 Pharmaceutical CDMO Services Segment by End User/Segment
      • 4.1.1 Innovative Medicine
      • 4.1.2 Patented Drug
      • 4.1.3 Patent Expired Drug
    • 4.2 Global Pharmaceutical CDMO Services Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Pharmaceutical CDMO Services Market Status by Region

    • 5.1 Global Pharmaceutical CDMO Services Market by Region
    • 5.2 North America Pharmaceutical CDMO Services Market Status
    • 5.3 Europe Pharmaceutical CDMO Services Market Status
    • 5.4 Asia Pacific Pharmaceutical CDMO Services Market Status
    • 5.5 Central & South America Pharmaceutical CDMO Services Market Status
    • 5.6 Middle East & Africa Pharmaceutical CDMO Services Market Status

    6 North America Pharmaceutical CDMO Services Market Status

    • 6.1 North America Pharmaceutical CDMO Services Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Pharmaceutical CDMO Services Market Status

    • 7.1 Europe Pharmaceutical CDMO Services Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Pharmaceutical CDMO Services Market Status

    • 8.1 Asia Pacific Pharmaceutical CDMO Services Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Pharmaceutical CDMO Services Market Status

    • 9.1 Central & South America Pharmaceutical CDMO Services Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Pharmaceutical CDMO Services Market Status

    • 10.1 Middle East & Africa Pharmaceutical CDMO Services Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Pharmaceutical CDMO Services Market Forecast by Category and by End User/Segment

    • 12.1 Global Pharmaceutical CDMO Services Sales Value Forecast (2022-2027)
    • 12.2 Global Pharmaceutical CDMO Services Forecast by Category
    • 12.3 Global Pharmaceutical CDMO Services Forecast by End User/Segment

    13 Global Pharmaceutical CDMO Services Market Forecast by Region/Country

    • 13.1 Global Pharmaceutical CDMO Services Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 WuXi AppTec Group
      • 14.1.1 Company Information
      • 14.1.2 Pharmaceutical CDMO Services Product Introduction
      • 14.1.3 WuXi AppTec Group Pharmaceutical CDMO Services Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Strides Pharma Science Limited
      • 14.2.1 Company Information
      • 14.2.2 Pharmaceutical CDMO Services Product Introduction
      • 14.2.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Siegfried Ltd
      • 14.3.1 Company Information
      • 14.3.2 Pharmaceutical CDMO Services Product Introduction
      • 14.3.3 Siegfried Ltd Pharmaceutical CDMO Services Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Recipharm AB
      • 14.4.1 Company Information
      • 14.4.2 Pharmaceutical CDMO Services Product Introduction
      • 14.4.3 Recipharm AB Pharmaceutical CDMO Services Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Piramal Pharma Solutions
      • 14.5.1 Company Information
      • 14.5.2 Pharmaceutical CDMO Services Product Introduction
      • 14.5.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Patheon N.V.
      • 14.6.1 Company Information
      • 14.6.2 Pharmaceutical CDMO Services Product Introduction
      • 14.6.3 Patheon N.V. Pharmaceutical CDMO Services Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Fareva Group
      • 14.7.1 Company Information
      • 14.7.2 Pharmaceutical CDMO Services Product Introduction
      • 14.7.3 Fareva Group Pharmaceutical CDMO Services Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 FAMAR Health Care Services
      • 14.8.1 Company Information
      • 14.8.2 Pharmaceutical CDMO Services Product Introduction
      • 14.8.3 FAMAR Health Care Services Pharmaceutical CDMO Services Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Catalent, Inc.
      • 14.9.1 Company Information
      • 14.9.2 Pharmaceutical CDMO Services Product Introduction
      • 14.9.3 Catalent, Inc. Pharmaceutical CDMO Services Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 AMRI Global
      • 14.10.1 Company Information
      • 14.10.2 Pharmaceutical CDMO Services Product Introduction
      • 14.10.3 AMRI Global Pharmaceutical CDMO Services Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Amatsigroup
    • 14.12 Aenova Group

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Pharmaceutical CDMO Services market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Pharmaceutical CDMO Services market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Drug Substance Development and Manufacturing
      Specialized Services
      Lab-based Services

      Segmented by End User/Segment
      Innovative Medicine
      Patented Drug
      Patent Expired Drug

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      WuXi AppTec Group
      Strides Pharma Science Limited
      Siegfried Ltd
      Recipharm AB
      Piramal Pharma Solutions
      Patheon N.V.
      Fareva Group
      FAMAR Health Care Services
      Catalent, Inc.
      AMRI Global
      Amatsigroup
      Aenova Group
      Buy now